Amplify Weight Loss Drug & Treatment ETF TMO Holdings History
Amplify Weight Loss Drug & Treatment ETF's Thermo Fisher Scientific Inc Holding Summary
As of 2025-03-31, Amplify Weight Loss Drug & Treatment ETF held 390.00 shares of Thermo Fisher Scientific Inc(TMO), totaling $194,060.00. This investment constitutes 5.15% of their stock portfolio, and Amplify Weight Loss Drug & Treatment ETF now holds 0% of the outstanding Thermo Fisher Scientific Inc(TMO) stock.
The initial trade took place in 2024Q2. And since then Amplify Weight Loss Drug & Treatment ETF has made 2 purchases of TMO, at an average price of $578.01, for a total of 417.00 shares. In addition, there have been 1 sales at an average price of $541.60 for 27.00 shares. Based on historical transaction data and TMO's current price of $417.83, Amplify Weight Loss Drug & Treatment ETF's estimated gain on his TMO holdings is $-63,452.34, reflecting a -26.33% gain to date.
Amplify Weight Loss Drug & Treatment ETF TMO ($417.83) Holding Chart
Amplify Weight Loss Drug & Treatment ETF TMO ($417.83) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
